BHSC — Bioharvest Sciences Balance Sheet
0.000.00%
- CA$137.76m
- CA$149.00m
- $12.67m
- 33
- 14
- 80
- 38
Annual balance sheet for Bioharvest Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 April 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.532 | 1.78 | 4.12 | 1.74 | 5.36 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.336 | 0.354 | 0.62 | 1.21 | 0.957 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.868 | 2.24 | 5.67 | 4.32 | 9.05 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 2.92 | 4.36 | 4.91 | 5.77 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 5.63 | 5.3 | 10.2 | 9.39 | 15 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.027 | 1.89 | 2.92 | 11.5 | 26.5 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.91 | 7.6 | 7.35 | 15.3 | 29.9 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.72 | -2.29 | 2.85 | -5.93 | -14.9 |
Total Liabilities & Shareholders' Equity | 5.63 | 5.3 | 10.2 | 9.39 | 15 |
Total Common Shares Outstanding |